Jupiter Life Line Hospitals (JLHL) Fundamentals 2026 — P/E 52.8x, Revenue Analysis | SniperIQ
Jupiter Life Line Hospitals (JLHL) is a India-listed Healthcare company in Medical - Care Facilities with a market capitalization of ₹10,242 Crore, trading at ₹1562.60 on the BSE. This SniperIQ fundamentals page covers Jupiter Life Line Hospitals's valuation (P/E 52.8x, P/B 6.6x), profitability (net margin 13.0%), revenue (₹1,500 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Jupiter Life Line Hospitals's market cap?
Jupiter Life Line Hospitals (JLHL) has a market capitalization of approximately ₹10,242 Crore, trading at ₹1562.60 on the BSE. Market cap moves with the live share price.
What is Jupiter Life Line Hospitals's P/E ratio?
Jupiter Life Line Hospitals's trailing twelve-month P/E ratio is 52.8x, with a price-to-book (P/B) of 6.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Jupiter Life Line Hospitals?
Jupiter Life Line Hospitals runs a net profit margin of 13.0%, a gross margin of 69.1%, and an operating margin of 17.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Jupiter Life Line Hospitals generate?
Jupiter Life Line Hospitals reported revenue of ₹1,500 Crore for fiscal year 2026, with net income of ₹194 Crore and earnings per share (EPS) of 29.59. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Jupiter Life Line Hospitals pay a dividend?
Jupiter Life Line Hospitals offers a trailing dividend yield of about 0.1%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Jupiter Life Line Hospitals financially healthy?
Jupiter Life Line Hospitals carries a debt-to-equity ratio of 0.38x and a current ratio of 3.02x, with a market beta of 0.19. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Jupiter Life Line Hospitals a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Jupiter Life Line Hospitals (JLHL) the key facts are: market cap ₹10,242 Crore, P/E 52.8x, revenue ₹1,500 Crore, 52-week range 1152.05-1618.15. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Jupiter Life Line Hospitals's full fundamentals live
Get Jupiter Life Line Hospitals's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.